Despite the transcending advance of CRISPR gene editing, interest in RNA editing is slowly catching on. A handful of companies are now launching projects banking on innovative technologies to draw investor attention.

Current research endeavors focus on the applications of the human RNA editing enzymes called ADARs (adenosine deaminase act on double-stranded RNA). ADAR enlists the help of guide RNA (gRNA), which shuttles it to a target location to carry out precise and efficient editing.

Here is our list of six companies and their research indications, target areas, and fundraising power to bring you up to speed on the frontrunners of a growing industry. GeneOnline lists emerging RNA editing companies that are set to make a mark in 2021